Repeated exposure to heterologous hepatitis C viruses associates with enhanced neutralizing antibody breadth and potency

A prophylactic hepatitis C virus (HCV) vaccine that elicits neutralizing antibodies could be key to HCV eradication. However, the genetic and antigenic properties of HCV envelope (E1E2) proteins capable of inducing anti-HCV broadly neutralizing antibodies (bNAbs) in humans have not been defined. Her...

Descripción completa

Detalles Bibliográficos
Autores principales: Frumento, Nicole, Figueroa, Alexis, Wang, Tingchang, Zahid, Muhammad N., Wang, Shuyi, Massaccesi, Guido, Stavrakis, Georgia, Crowe, James E., Flyak, Andrew I., Ji, Hongkai, Ray, Stuart C., Shaw, George M., Cox, Andrea L., Bailey, Justin R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9337827/
https://www.ncbi.nlm.nih.gov/pubmed/35588376
http://dx.doi.org/10.1172/JCI160058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9337827/
https://www.ncbi.nlm.nih.gov/pubmed/35588376
http://dx.doi.org/10.1172/JCI160058

Ejemplares similares